A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density
出版年份 2013 全文链接
标题
A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 8, Pages e72938
出版商
Public Library of Science (PLoS)
发表日期
2013-08-24
DOI
10.1371/journal.pone.0072938
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Abstract P5-18-09: A Phase I Study of MM-302, a HER2-targeted Liposomal Doxorubicin, in Patients with Advanced, HER2- Positive Breast Cancer
- (2014) T Wickham et al. CANCER RESEARCH
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- From Phage Display to Nanoparticle Delivery: Functionalizing Liposomes with Multivalent Peptides Improves Targeting to a Cancer Biomarker
- (2012) Bethany Powell Gray et al. BIOCONJUGATE CHEMISTRY
- Pericyte-Coverage of Human Tumor Vasculature and Nanoparticle Permeability
- (2012) Liuzhe Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Analysis on the current status of targeted drug delivery to tumors
- (2012) Il Keun Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and biological evaluation of a peptide–paclitaxel conjugate which targets the integrin αvβ6
- (2011) Shunzi Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- Pegylated Liposomal Doxorubicin
- (2011) Sean T. Duggan et al. DRUGS
- Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature
- (2011) Thomas P. Herringson et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway
- (2011) Takahiro Seki et al. JOURNAL OF CONTROLLED RELEASE
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Efficacy, Biodistribution, and Pharmacokinetics of CD22-Targeted Pegylated Liposomal Doxorubicin in a B-cell Non-Hodgkin's Lymphoma Xenograft Mouse Model
- (2010) J. M. Tuscano et al. CLINICAL CANCER RESEARCH
- Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
- (2010) Yasufumi Katanasaka et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors
- (2010) Amanda Lowery et al. JOURNAL OF CONTROLLED RELEASE
- Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid
- (2010) Thomas P. Herringson et al. JOURNAL OF DRUG TARGETING
- Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors
- (2009) De-Kuan Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanosystem drug targeting: Facing up to complex realities
- (2009) Pakatip Ruenraroengsak et al. JOURNAL OF CONTROLLED RELEASE
- Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung
- (2009) Ludmila Prudkin et al. MODERN PATHOLOGY
- Synthesis and characterization of a high-affinity v 6-specific ligand for in vitro and in vivo applications
- (2009) S. Li et al. MOLECULAR CANCER THERAPEUTICS
- A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
- (2009) M. M. Schmidt et al. MOLECULAR CANCER THERAPEUTICS
- Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
- (2009) Steven D. Perrault et al. NANO LETTERS
- A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer
- (2009) De-Kuan Chang et al. PLoS One
- Cooperative nanomaterial system to sensitize, target, and treat tumors
- (2009) J.-H. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
- (2008) F. Pastorino et al. CLINICAL CANCER RESEARCH
- Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo
- (2008) Shuxian Song et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
- (2008) A. Lo et al. MOLECULAR CANCER THERAPEUTICS
- Does a targeting ligand influence nanoparticle tumor localization or uptake?
- (2008) Kathleen F. Pirollo et al. TRENDS IN BIOTECHNOLOGY
- Overexpression of the αvβ6 Integrin in Endometrial Cancer
- (2008) Jonathan L. Hecht et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now